Safety of MR-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas

Journal of Therapeutic Ultrasound

Elizabeth A Stewart²  Krzysztof R Gorny¹  Gina K Hesley¹  Douglas L Brown¹ 

[1] Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA;Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

关键词: Pedunculated leiomyoma;    Safety;    Magnetic resonance;    Uterus;    Ultrasound;    Ablation;   

Others  :  801379
DOI  :  10.1186/2050-5736-1-19

 received in 2013-05-24, accepted in 2013-08-20,  发布年份 2013

【 摘 要 】

Background

There has previously been a concern about whether it is safe to use minimally invasive methods to treat pedunculated subserosal uterine leiomyomas. The purpose of our study is to evaluate the safety of magnetic resonance-guided focused ultrasound (MRgFUS) ablation of pedunculated subserosal uterine leiomyomas.

Methods

All cases of MRgFUS ablations performed at our institution from March 2005 through March 2010 were reviewed to identify patients in whom a pedunculated subserosal leiomyoma was treated. Follow-up clinical and surgical data were reviewed to assess for complications.

Results

A pedunculated leiomyoma was treated in 11 of 179 patients. Only two of the 11 patients had complications, both of which were minor and likely unrelated specifically to the pedunculated leiomyomas. One patient had transient lumbar plexopathy contralateral to the pedunculated leiomyoma, and one patient had transient voiding difficulty. Operative findings in three other patients who subsequently had myomectomy or hysterectomy found no adhesions or other complications related to the pedunculated leiomyomas.

Conclusions

Pedunculated subserosal leiomyomas are not a contraindication to treatment by MRgFUS. We found no evidence of complications specifically related to pedunculated subserosal leiomyomas.

【 授权许可】

   
2013 Brown et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Fennessy FM, Tempany CM, McDannold NJ, So MJ, Hesley G, Gostout B, Kim HS, Holland GA, Sarti DA, Hynynen K, Jolesz FA, Stewart EA: Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–results of different treatment protocols. Radiology. 2007, 243:885-93.
• [2]Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM: Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007, 110:279-87.
• [3]Taran FA, Tempany CM, Regan L, Inbar Y, Revel A, Stewart EA: Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol. 2009, 34:572-78.
• [4]Andrews RT, Spies JB, Sacks D, Worthington-Kirsch RL, Niedzwiecki GA, Marx MV, Hovsepian DM, Miller DL, Siskin GP, Raabe RD, Goodwin SC, Min RJ, Bonn J, Cardella JF, Patel NH: Patient care and uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 2004, 15:115-20.
• [5]Braude P, Reidy J, Nott V, Taylor A, Forman R: Embolization of uterine leiomyomata: current concepts in management. Hum Reprod Update. 2000, 6:603-08.
• [6]Katsumori T, Akazawa K, Mihara T: Uterine artery embolization for pedunculated subserosal fibroids. AJR Am J Roentgenol. 2005, 184:399-402.
• [7]Margau R, Simons ME, Rajan DK, Hayeems EB, Sniderman KW, Tan K, Beecroft JR, Kachura JR: Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. J Vasc Interv Radiol. 2008, 19:657-61.
• [8]Smeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HA, van Rooij WJ, de Vries J, Lohle PN: Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. J Vasc Interv Radiol. 2009, 20:1172-75.
• [9]Taran FA, Hesley GK, Gorny KR, Stewart EA: What factors currently limit magnetic resonance-guided focused ultrasound of leiomyomas? A survey conducted at the first international symposium devoted to clinical magnetic resonance-guided focused ultrasound. Fertil Steril. 2010, 94:331-34.
• [10]Gorny KR, Hangiandreou NJ, Hesley GK, Gostout BS, McGee KP, Felmlee JP: MR guided focused ultrasound: technical acceptance measures for a clinical system. Phys Med Biol. 2006, 51:3155-73.
• [11]Gorny KR, Woodrum DA, Brown DL, Henrichsen TL, Weaver AL, Amrami KK, Hangiandreou NJ, Edmonson HA, Bouwsma EV, Stewart EA, Gostout BS, Ehman DA, Hesley GK: Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol. 2011, 22:857-64.
• [12]Hesley GK, Felmlee JP, Gebhart JB, Dunagan KT, Gorny KR, Kesler JB, Brandt KR, Glantz JN, Gostout BS: Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc. 2006, 81:936-42.
• [13]Hesley GK, Gorny KR, Henrichsen TL, Woodrum DA, Brown DL: A clinical review of focused ultrasound ablation with magnetic resonance guidance: an option for treating uterine fibroids. Ultrasound Q. 2008, 24:131-39.
• [14]Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, Worthington-Kirsch RL: Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol. 2001, 12:1011-20.
• [15]Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Hesley G, Kim HS, Hengst S, Gedroyc WM: Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006, 85:22-9.
• [16]Park H, Yoon S, Kim K, Kim DJ, Jung S: Magnetic resonsance imaging-guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: a preliminary report. J Vasc Interv Radiol. 2012, 23:1589-93.